Drugs / GVAX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00133224 | Jul 2005 → Aug 2008 | prostate cancer | Cell Genesys | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GVAX | “patients receiving docetaxel in combination with the GVAX® vaccine for prostate cancer” NCT00133224 ↗ |
| Modality | Vaccine | “GVAX® vaccine for prostate cancer” NCT00133224 ↗ |